707Indexed trials
canonical disease area
Parkinson's Disease
Intelligence
Parkinson's Disease intelligence: 707 indexed trials, 155 recruiting studies, 422 sponsors across 66 countries.
155Recruiting
422Sponsors
66Countries
Leading sponsors
Merck Sharp & Dohme LLC3211 recruiting
Bial - Portela C S.A.80 recruiting
AbbVie81 recruiting
Washington University School of Medicine83 recruiting
National Institute of Neurological Disorders and Stroke (NINDS)81 recruiting
InSightec74 recruiting
Radboud University Medical Center71 recruiting
UCB Pharma60 recruiting
VA Office of Research and Development64 recruiting
Boehringer Ingelheim60 recruiting
University Hospital, Toulouse61 recruiting
University of Michigan63 recruiting
Geographic activity
United States301trials
France76trials
Italy68trials
Germany67trials
Spain64trials
Canada63trials
United Kingdom56trials
China49trials
Turkey (Türkiye)38trials
Taiwan36trials
Israel36trials
Brazil33trials
Leading interventions
Pembrolizumab21trials
Carboplatin11trials
Cisplatin10trials
Paclitaxel6trials
Deep Brain Stimulation6trials
Rotigotine6trials
tDCS5trials
Exercise4trials
Transcranial direct current stimulation4trials
Pimavanserin4trials
Gemcitabine4trials
Pramipexole4trials
Methodology note
This entity is derived from structured ClinicalTrials.gov conditions and/or MeSH normalization. Counts reflect the current NeuroRisk indexed corpus and are not guaranteed exhaustive global totals.